Trial Profile
A Pilot Study of Using Statins in Patients With Acute Venous Thromboembolism (VTE)
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Warfarin
- Indications Venous thromboembolism
- Focus Pharmacodynamics
- 23 Sep 2020 Status changed from recruiting to discontinued.
- 06 Apr 2018 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
- 06 Apr 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Apr 2019.